Zhejiang Xinguang Pharmaceutical Co., Ltd.
SHZ: 300519.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yue Jun Wang
- Employees
- 315
- Headquarters
- Shengzhou, China
- IPO year
- 2016
- Market cap
- CN¥2.7B
- Website
- https://www.xgpharma.com
Loading 300519…
Loading profile data…Frequently asked questions about 300519
What does Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ) do?
Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health foods. The company offers pharmaceutical products in the areas of cardiovascular and cerebrovascular diseases, and traumatic diseases, covering the aspects of respiratory system, di...
Where does 300519.SZ trade?
Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300519.SZ in?
Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Zhejiang Xinguang Pharmaceutical Co., Ltd.?
Yue Jun Wang is the chief executive officer of Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ).
Where is Zhejiang Xinguang Pharmaceutical Co., Ltd. headquartered?
Zhejiang Xinguang Pharmaceutical Co., Ltd. is headquartered in China.
Does 300519.SZ pay a dividend?
Yes — Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ) paid a trailing twelve-month dividend of CNY 0.30 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300519.SZ go public?
Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ) completed its initial public offering in 2016.